Variant report
Variant | nsv582087 |
---|---|
Chromosome Location | chr2:57514400-57552087 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FANCL-2 | chr2:57542599-57542640 | XLOC_002102 |
2 | lnc-FANCL-2 | chr2:57541337-57541655 | NONHSAT070831 |
3 | lnc-FANCL-2 | chr2:57541338-57541655 | XLOC_002102 |
4 | lnc-FANCL-2 | chr2:57542598-57542640 | NONHSAT070831 |
No data |
No data |
Variant related genes | Relation type |
---|---|
SPRY4 | miRNA target sites |
TSC1 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs141334829 | chr2:57518603-57518604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs547509833 | chr2:57518627-57518628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs183369118 | chr2:57518628-57518629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs116670708 | chr2:57518648-57518649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs1522760 | chr2:57518671-57518672 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs144971254 | chr2:57518725-57518726 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs543350833 | chr2:57518733-57518734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs562929704 | chr2:57518757-57518758 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs72939658 | chr2:57518773-57518774 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs574411734 | chr2:57519403-57519404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs146095195 | chr2:57519412-57519413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536254620 | chr2:57519475-57519476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs565732785 | chr2:57519481-57519482 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs57055298 | chr2:57519482-57519483 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs145225148 | chr2:57539201-57539202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs553621090 | chr2:57539205-57539206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs17805484 | chr2:57539209-57539210 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs540681701 | chr2:57539223-57539224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs76605163 | chr2:57539258-57539259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs80098883 | chr2:57539301-57539302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs543044686 | chr2:57539339-57539340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs542264899 | chr2:57539343-57539344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs562830967 | chr2:57539352-57539353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs562619857 | chr2:57539373-57539374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs149142172 | chr2:57539398-57539399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs551152010 | chr2:57539415-57539416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs564698720 | chr2:57539427-57539428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs182201214 | chr2:57539438-57539439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs547054688 | chr2:57539471-57539472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs10178543 | chr2:57539475-57539476 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs1357378 | chr2:57539489-57539490 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
32 | rs549793577 | chr2:57539499-57539500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs569439762 | chr2:57539504-57539505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs542095024 | chr2:57539524-57539525 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs538497483 | chr2:57539526-57539527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs78134281 | chr2:57539527-57539528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs578194664 | chr2:57539531-57539532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs545148740 | chr2:57539549-57539550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs78588593 | chr2:57539560-57539561 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs76361044 | chr2:57539590-57539591 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs376571274 | chr2:57539609-57539610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs187209174 | chr2:57539629-57539630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs116481759 | chr2:57539634-57539635 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs542654838 | chr2:57539646-57539647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs562942750 | chr2:57539676-57539677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs576038592 | chr2:57539684-57539685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs149275840 | chr2:57539708-57539709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs199505177 | chr2:57539709-57539710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs540995189 | chr2:57539720-57539721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs201397291 | chr2:57539722-57539723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 19951919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Microcephaly | 20799320 | CNVD |
camptodactyly | 20799320 | CNVD |
cognitive delay | 20799320 | CNVD |
prenatal and postnatal growth deficiency | 20799320 | CNVD |
ptosis of eyelids | 20799320 | CNVD |
Maculopathy | 20981449 | CNVD |
2p16.1 microdeletion syndrome | 22283845 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:57518600-57518800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr2:57518600-57518800 | Enhancers | Pancreas | Pancrea |
3 | chr2:57519400-57519600 | Enhancers | Pancreas | Pancrea |
4 | chr2:57539200-57539400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr2:57539400-57540400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr2:57540400-57541200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
7 | chr2:57540400-57541200 | Enhancers | HMEC | breast |
8 | chr2:57540400-57542800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
9 | chr2:57540600-57541200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |